Other key regulation features are restrictions on imported drugs (where these are produced by four or more local firms), a ban on local production of around 1,700 drugs that are considered non-essential or harmful and strict price controls on some 117 principal medicines.
Additional regulations involve limitations on imported medications (produced by four or more domestic firms), a prohibition on the manufacture of roughly 1,700 drugs considered unnecessary or dangerous, and stringent pricing controls for around 117 key pharmaceuticals.